Berobenatide
VESPER-1
Pfizer · Phase 2 · Completed · Enrollment 239
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| MET097 Active | n/r | n/r | n/r | n/r | n/r |
| Placebo | 13 participants | 6 participants | 5 participants | n/r | 0 |
A count stays a count. This page does not turn a count into a percent.